NCT03257631 2024-04-16A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain TumorsCelgenePhase 2 Completed53 enrolled 18 charts
NCT02415153 2022-04-25Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsNational Cancer Institute (NCI)Phase 1 Completed29 enrolled